| Name | Title | Contact Details |
|---|
Hyaluron is a Burlington, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
PharMerica (NYSE: PMC) is a publicly traded Fortune 1000 company formed in January 2007 from the merger of Kindred Healthcare's pharmacy business with a subsidiary of AmerisourceBergen. The company is headquartered in Louisville, Kentucky, and operates a major customer support center in Tampa, Florida. The new company is the second largest in the institutional pharmacy services market, with revenues of $1.9 billion and a customer base of 330,000 "beds" in 41 U.S. states.
It has exclusively licensed a clinically validated virus-like particle (VLP) platform from Cytos Biotechnology Ltd (SIX:CYTN) for the field of oncology, that includes the clinical product (CYT003) and technologies related to oligonucleotide synthesis and VLP delivery. CYT003 is a product derived from the CpG class of oligonucleotides that activates the immune system via Toll-like receptor 9 (TLR9) and has the potential to improve efficacy outcomes and broaden the size of the populations that can benefit from checkpoint inhibitor therapies.
Y's Therapeutics, Inc is a San Bruno, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
JSJ Pharmaceuticals is a Charleston, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.